Clinical Trials

• 10/22/2024

  “GE HealthCare Launches AI-Powered Cancer Diagnosis Tool”

• 10/21/2024

  3 Dividend Growth Stocks for a Lifetime of Passive Income

• 10/8/2024

  **Anavex Stock: Risky CNS Drug Development Bet Downgraded**

• 10/7/2024

  **2 Stocks Poised to Soar 112% and 120%**

• 

  10/4/2024

  **Can This Broken Immunology IPO Become a Biotech Giant?**

• 10/2/2024

  **FDA Approves Phase 1 Trials for AI-Discovered Cancer Treatment**

• 10/1/2024

  **Camp4 Therapeutics Eyes IPO After Early Success**

• 9/30/2024

  **Mesoblast: Undervalued with Strong Growth Potential**

• 9/29/2024

  **2 Hidden Gems for Your Portfolio**

• 9/28/2024

  **FDA Approves Groundbreaking Schizophrenia Treatment**